跳至主要内容
临床试验/NCT01273363
NCT01273363已完成不适用

Non-interventional Retrospective Multicenter Study of Patients With Bronchial Asthma During a Routine Visit to Out of Patients' Clinics

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2010年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,000
试验地点
1
主要终点
To assess asthma control in Russian patients acc. to the new criteria in the international guidelines (Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice) and identify pharmacological approaches provided a higher level of control

研究概览

简要总结

To assess asthma control in Russian patients according to the new criteria provided in the international guidelines and identify pharmacological approaches that provide a higher level of overall asthma control

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male and female patients over 18 years of age
  • •Patients with asthma diagnosed in accordance with the Global Initiative for Asthma (GINA [xv]) within 6 months before inclusion into the study. Patients with no changes in their treatment within 2 months before inclusion into the study
  • •Patients who signed their informed consents to collection and further processing of data on their disease course

排除标准

  • •Asthma patients with an exacerbation at the moment of inclusion.
  • •Patients on β-blockers.
  • •Patients with COPD, mucoviscidosis or bronchiectasis, Severe heart failure (NYHA functional class III-IV), Renal insufficiency, Cancer, Previous stroke.
  • •Pregnant women.
  • •Patients following a major surgery, Hepatic insufficiency.

结局指标

主要结局

To assess asthma control in Russian patients acc. to the new criteria in the international guidelines (Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice) and identify pharmacological approaches provided a higher level of control

时间窗: 1 visit for 3 month

次要结局

  • To determine the main demographic, clinical and pharmacoepidemiological characteristics of low-control patients.(1 visit for 3 month)
  • To assess comparative value of the Asthma Control Questionnaire (ACT) and Asthma Control Questionnaire (ACQ) with regard to their use in clinical practice in Russia(1 visit for 3 month)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验